Top Markets
#1 Cross Cross +16.09%
#2 Glidr Glidr +10.10%
#3 Gama Token Gama Token +8.43%
#4 Palladium Network Palladium Network +5.01%
#5 Based Based +4.88%
#6 TDCCP TDCCP +4.76%
#7 Akedo Akedo +4.66%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.64%
#9 LEO Token LEO Token +4.36%
#10 Pieverse Pieverse +4.24%
Coin of the day
Cross Cross
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Rangering i aksjer #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Aksjekurs
$0.14966934
Sist synkronisert: 2026-08-14
Markedsverdi
$3.02M
Endring (1 dag)
3.72%
Endring (1 år)
-93.70%
Land
SE
Handel Guard Therapeutics International AB (publ) (GUARD)

Kategori

Healthcare
Inntekter for Guard Therapeutics International AB (publ) (GUARD)
Inntekter i 2026 TTM: 0
Ifølge Guard Therapeutics International AB (publ) sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Guard Therapeutics International AB (publ) fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE